EMEA-001930-PIP01-16-M04

Table of contents

Key facts

Invented name
MenQuadfi
Active substance
  • Neisseria meningitidis serogroup A polysaccharide conjugated to tetanus toxoid
  • N. meningitidis serogroup C polysaccharide conjugated to tetanus toxoid
  • N. meningitidis serogroup Y polysaccharide conjugated to tetanus toxoid
  • N. meningitidis serogroup W polysaccharide conjugated to tetanus toxoid (MenACYW)
Therapeutic area
Vaccines
Decision number
P/0222/2022
PIP number
EMEA-001930-PIP01-16-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of invasive meningococcal disease
Route(s) of administration
Intramuscular use
Contact for public enquiries
Sanofi Pasteur

Tel.  +33 169745695
E-mail: contact-us@sanofi.com

 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
View 1 rating
1 rating